003220.KS
Daewon Pharmaceutical Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 7,700.00
−0.77%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- KRW 157
- Revenue estimate
- KRW 145.8B
Latest reported
- Last report date
- Aug 7, 2026
- EPS actual
- KRW 188
- EPS estimate
- KRW 115
- Revenue actual
- KRW 152.2B
- Revenue estimate
- KRW 152.2B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +63.8%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 7, 2026 | KRW 115 | KRW 188 | Beat 63.82% | KRW 152.2B |
| May 15, 2026 | — | KRW 113 | — | KRW 158.1B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026